1,487
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Meisoindigo, but not its core chemical structure indirubin, inhibits zebrafish interstitial leukocyte chemotactic migration

, , , , , , , & show all
Pages 673-679 | Received 23 Apr 2016, Accepted 16 Sep 2016, Published online: 16 Dec 2016

References

  • Blazevic T, Heiss EH, Atanasov AG, Breuss JM, Dirsch VM, Uhrin P. 2015. Indirubin and indirubin derivatives for counteracting proliferative diseases. Evid Based Complement Alternat Med. 2015:654098.
  • Camps M, Ruckle T, Ji H, Ardissone V, Rintelen F, Shaw J, Ferrandi C, Chabert C, Gillieron C, Francon B, et al. 2005. Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat Med. 11:936–943.
  • Dinarello CA. 2010. Anti-inflammatory agents: present and future. Cell. 140:935–950.
  • Friedl P, Weigelin B. 2008. Interstitial leukocyte migration and immune function. Nat Immunol. 9:960–969.
  • Hall C, Flores MV, Storm T, Crosier K, Crosier P. 2007. The zebrafish lysozyme C promoter drives myeloid-specific expression in transgenic fish. BMC Dev Biol. 7:42.
  • Hoessel R, Leclerc S, Endicott JA, Nobel ME, Lawrie A, Tunnah P, Leost M, Damiens E, Marie D, Marko D, et al. 1999. Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. Nat Cell Biol. 1:60–67.
  • Cooperative Group of Clinical Therapy of Indirubin. 1980. Clinical studies of 314 cases of CML treated with indirubin. Chin J Hematol. 1:132–135.
  • Ji XJ, Zhang FR, Liu Y, Gu QM. 1985. Studies on antieoplastic action of N-methylisoiindigotin. Acta Pharm Sin. 20:247–251.
  • Ji XJ, Zhang FR. 1985. Studies on antineoplastic action of indirubin derivatives and analogs and their structure–activity relationships. Acta Pharm Sin. 20:137–139.
  • Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF. 1995. Stages of embryonic development of the zebrafish. Dev Dyn. 203:253–310.
  • Lieschke GJ, Currie PD. 2007. Animal models of human disease: zebrafish swim into view. Nat Rev Genet. 8:353–367.
  • Liu B, Wang Y, Hao C, Liu Y, Qian L. 2001. [Observation of long-term therapeutic outcome in chronic granulocytic leukemia]. Zhonghua Xue Ye Xue Za Zhi. 22:61–63.
  • Liu YJ, Fan HB, Jin Y, Ren CG, Jia XE, Wang L, Chen Y, Dong M, Zhu KY, Dong ZW, et al. 2013. Cannabinoid receptor 2 suppresses leukocyte inflammatory migration by modulating the JNK/c-Jun/Alox5 pathway. J Biol Chem. 288:13551–13562.
  • Mackay CR. 2008. Moving targets: cell migration inhibitors as new anti-inflammatory therapies. Nat Immunol. 9:988–998.
  • Mathias JR, Perrin BJ, Liu TX, Kanki J, Look AT, Huttenlocher A. 2006. Resolution of inflammation by retrograde chemotaxis of neutrophils in transgenic zebrafish. J Leukoc Biol. 80:1281–1288.
  • Medzhitov R. 2010. Inflammation 2010: new adventures of an old flame. Cell. 140:771–776.
  • Nathan C, Ding A. 2010. Nonresolving inflammation. Cell. 140:871–882.
  • Niethammer P, Grabher C, Look AT, Mitchison TJ. 2009. A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish. Nature. 459:996–999.
  • Nowak PJ, Zasowska-Nowak A, Bialasiewicz P, de Graft-Johnson J, Nowak D, Nowicki M. 2015. Inhibitory effect of plant phenolics on fMLP-induced intracellular calcium rise and chemiluminescence of human polymorphonuclear leukocytes and their chemotactic activity in vitro. Pharm Biol. 53:1661–1670.
  • Ren DL, Sun AA, Li YJ, Chen M, Ge SC, Hu B. 2015. Exogenous melatonin inhibits neutrophil migration through suppression of ERK activation. J Endocrinol. 227:49–60.
  • Renshaw SA, Loynes CA, Trushell DM, Elworthy S, Ingham PW, Whyte MK. 2006. A transgenic zebrafish model of neutrophilic inflammation. Blood. 108:3976–3978.
  • Robertson AL, Holmes GR, Bojarczuk AN, Burgon J, Loynes CA, Chimen M, Sawtell AK, Hamza B, Willson J, Walmsley SR, et al. 2014. A zebrafish compound screen reveals modulation of neutrophil reverse migration as an anti-inflammatory mechanism. Sci Transl Med. 6:225–229.
  • Sapharikas E, Lokajczyk A, Fischer AM, Boisson-Vidal C. 2015. Fucoidan stimulates monocyte migration via ERK/p38 signaling pathways and MMP9 secretion. Mar Drugs. 13:4156–4170.
  • Thompson CB. 2009. Attacking cancer at its root. Cell. 138:1051–1054.
  • Tobin David M, Roca Francisco J, Oh Sungwhan F, McFarland R, Vickery Thad W, Ray John P, Ko Dennis C, Zou Y, Bang Nguyen D, Chau Tran TH, et al. 2012. Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections. Cell. 148:434–446.
  • Trede NS, Langenau DM, Traver D, Look AT, Zon LI. 2004. The use of zebrafish to understand immunity. Immunity. 20:367–379.
  • Volpe S, Thelen S, Pertel T, Lohse MJ, Thelen M. 2010. Polarization of migrating monocytic cells is independent of PI 3-kinase activity. PLoS One. 5:e10159.
  • Wang L, Zhou GB, Liu P, Song JH, Liang Y, Yan XJ, Xu F, Wang BS, Mao JH, Shen ZX, et al. 2008. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proc Natl Acad Sci USA. 105:4826–4831.
  • Wee XK, Yeo WK, Zhang B, Tan VB, Lim KM, Tay TE, Go ML. 2009. Synthesis and evaluation of functionalized isoindigos as antiproliferative agents. Bioorg Med Chem. 17:7562–7571.
  • Wu KM, Zhang MY, Fang Z, Huang L. 1984. Synthesis of N1-substituted derivatives of indirubin, an antileukemic compound. Acta Pharm Sin. 19:6.
  • Wu KM, Zhang MY, Fang Z, Hung L. 1985. Potential antileukemic agents, synthesis of derivatives of indirubin, indigo, and isoindigotin. Acta Pharm Sin. 20:6.
  • Xiao Z, Hao Y, Liu B, Qian L. 2002. Indirubin and meisoindigo in the treatment of chronic myelogenous leukemia in China. Leuk Lymphoma. 43:1763–1768.
  • Yaniv K, Isogai S, Castranova D, Dye L, Hitomi J, Weinstein BM. 2006. Live imaging of lymphatic development in the zebrafish. Nat Med. 12:711–716.
  • Ye BX, Deng X, Shao LD, Lu Y, Xiao R, Liu YJ, Jin Y, Xie YY, Zhao Y, Luo LF, et al. 2015. Vibsanin B preferentially targets HSP90β, inhibits interstitial leukocyte migration, and ameliorates experimental autoimmune encephalomyelitis. J Immunol. 194:4489–4497.
  • Yoder JA, Nielsen ME, Amemiya CT, Litman GW. 2002. Zebrafish as an immunological model system. Microbes Infect. 4:1469–1478.
  • Yoo SK, Deng Q, Cavnar PJ, Wu YI, Hahn KM, Huttenlocher A. 2010. Differential regulation of protrusion and polarity by PI3K during neutrophil motility in live zebrafish. Dev Cell. 18:226–236.
  • Yoo SK, Starnes TW, Deng Q, Huttenlocher A. 2011. Lyn is a redox sensor that mediates leukocyte wound attraction in vivo. Nature. 480:109–112.
  • Zhang HJ, Zhang Y, Jin J, Zhou WQ, Chen XG. 2013. [Mechanism about therapeutic effect of meisoindigo on psoriasis via down-regulation of the TLR4-TAK-NF-kappaB pathways]. Yao Xue Xue Bao. 48:503–507.
  • Zhang Y, Bai XT, Zhu KY, Jin Y, Deng M, Le HY, Fu YF, Chen Y, Zhu J, Look AT, et al. 2008. In vivo interstitial migration of primitive macrophages mediated by JNK-matrix metalloproteinase 13 signaling in response to acute injury. J Immunol. 181:2155–2164.
  • Zheng QT, Qi SB, Cheng ZY. 1979. Pharmacologic studies of indirubin. II. Absorption distribution and exeretion of 3Hindirubin. Comm Chin Herb Med. 10:3.
  • Zon LI, Peterson RT. 2005. In vivo drug discovery in the zebrafish. Nat Rev Drug Discov. 4:35–44.